Catania (Italy), 28-29/01/2023.
iToBoS was presented at the Giornate di Therapia in Dermovenereolgia, XX Reunione.
Dr. Josep Malvehy, member of Fundació Clínic per a la Recerca Biomèdica, scientific partner of the iToBoS Project, presented the talk titled “New treatments of large field of cancerisation”.
In his talk, Dr Malvehy discussed the common myths related to the diagnosis, progression and treatment of Actinic Keratosis (AK) and Squamous Cell Carcinoma (SCC). The incidence of SCC in increasing, and risk of progression from AK to SCC is up to 20% per year. Those with AKs are up to 6 times higher risk of developing a non-melanoma skin cancer (NMSC), and it has been estimated that for every visible clinical lesion, there are 10 subclinical lesions that are not yet visible.
Dr Malvehy described the common non-invasive imaging technologies that are useful in guiding monitoring and treatment of NMSC, also mentioning the iToBoS project, which aims to develop an imaging platform for monitoring and detecting skin cancers.
Find out more at Giornate di Terapia in Dermovenereologia.